Molina Healthcare (NYSE:MOH) PT Lowered to $375.00

Molina Healthcare (NYSE:MOH) had its target price decreased by Wells Fargo & Company from $410.00 to $375.00 in a research note issued to investors on Monday, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

Several other research firms have also recently issued reports on MOH. Bank of America downgraded shares of Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price target for the company. in a report on Thursday, March 28th. Barclays cut their price target on Molina Healthcare from $437.00 to $430.00 and set an equal weight rating for the company in a report on Thursday, April 25th. StockNews.com cut Molina Healthcare from a strong-buy rating to a buy rating in a report on Thursday, February 8th. Truist Financial upped their target price on Molina Healthcare from $435.00 to $460.00 and gave the company a buy rating in a research note on Tuesday, February 20th. Finally, Stephens reissued an equal weight rating and issued a $390.00 price target on shares of Molina Healthcare in a research note on Thursday, April 25th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Molina Healthcare has an average rating of Hold and an average target price of $397.20.

Molina Healthcare Stock Up 0.5 %

Shares of NYSE MOH opened at $343.99 on Monday. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. The firm’s 50-day moving average is $389.18 and its two-hundred day moving average is $372.38. Molina Healthcare has a 12-month low of $266.35 and a 12-month high of $423.92. The company has a market capitalization of $20.16 billion, a PE ratio of 18.66, a price-to-earnings-growth ratio of 0.96 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The firm had revenue of $9.93 billion for the quarter, compared to analysts’ expectations of $9.45 billion. During the same quarter in the prior year, the firm earned $5.81 EPS. Molina Healthcare’s quarterly revenue was up 21.9% on a year-over-year basis. Equities analysts anticipate that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the transaction, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Richard M. Schapiro sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the completion of the sale, the director now owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders have sold a total of 16,711 shares of company stock valued at $6,472,517 over the last ninety days. Corporate insiders own 1.11% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in MOH. Vanguard Group Inc. increased its stake in Molina Healthcare by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 6,585,954 shares of the company’s stock worth $2,379,571,000 after buying an additional 23,715 shares during the period. Capital World Investors increased its position in shares of Molina Healthcare by 0.3% during the fourth quarter. Capital World Investors now owns 5,490,147 shares of the company’s stock worth $1,983,645,000 after acquiring an additional 14,775 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of Molina Healthcare by 12.8% in the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock worth $1,384,215,000 after acquiring an additional 436,060 shares in the last quarter. Capital Research Global Investors boosted its holdings in Molina Healthcare by 5.4% in the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock valued at $878,086,000 after purchasing an additional 123,894 shares during the last quarter. Finally, FMR LLC grew its stake in Molina Healthcare by 1.0% during the 3rd quarter. FMR LLC now owns 2,175,796 shares of the company’s stock valued at $713,422,000 after purchasing an additional 22,583 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.